SNPHYSanten Pharmaceutical Co., Ltd.$ --
Santen Pharmaceutical Co., Ltd.
SNPHY
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
wallet
Earnings SummaryUpdated: 12/31/2025FY2026 Q3
Revenue
74,200M JPY
YoY -2.8%
Operating Income
10,460M JPY
YoY -11.2%
Net Income
8,017M JPY
YoY -7.8%
EPS
24.86JPY
YoY -1.8%
Revenue
JPY213.3B
Actual
JPY-9.5B (-4.3%)
Net Income
JPY22.1B
Actual
JPY-5.4B (-19.5%)
Surprise History
Actual RevenueAnalyst Estimate
FY2020
Actual:JPY241.6B
FY2020
FY2021
Actual:JPY249.6B
FY2021
FY2022
Actual:JPY266.3B
FY2022
FY2023
Actual:JPY279B
FY2023
FY2024
Actual:JPY302B
FY2024
FY2025MISS
Actual:JPY300B
Est:JPY43.5T
FY2025MISS